[ad_1] Biocon and its partner Mylan announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) had issued a positive opinion in which they recommended …
Read More »Biocon moves closer to European approval of biosimilar trastuzumab
